BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:08 PM
 | 
Mar 26, 2009
 |  BC Extra  |  Company News

Dyax gets Kalbitor complete response

Dyax (NASDAQ:DYAX) received a complete response letter from FDA for a BLA for Kalbitor ecallantide ( DX-88) to treat acute attacks...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >